特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
954031

遺伝子治療の世界市場:細胞タイプ、ベクタータイプ、用途、エンドユーザー、地域別、COVID-19の潜在的な影響に関する洞察と予測(2020年~2024年)

Global Gene Therapy Market (by Cell Type, Vector Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版日: | 発行: Koncept Analytics | ページ情報: 英文 144 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
遺伝子治療の世界市場:細胞タイプ、ベクタータイプ、用途、エンドユーザー、地域別、COVID-19の潜在的な影響に関する洞察と予測(2020年~2024年)
出版日: 2020年08月17日
発行: Koncept Analytics
ページ情報: 英文 144 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子治療市場は、2020年から2024年の間に19.29%のCAGRで成長する見通しで、2024年には64億2,000万米ドルに達すると予測されています。同市場の主な成長要因には、慢性疾患の有病率の増加、ヘルスケア費の増加、都市化の拡大、遺伝子治療の臨床試験の成長、経済成長の急増などが挙げられます。今後は、個別化医療の急速な採用、遺伝性疾患の発生の増加、遺伝子治療の進歩、研究開発資金の増加などの動向が予測されています。ただし、遺伝子治療の副作用と倫理的および安全性の懸念、治療の高いコストが同市場の課題となっています。

当レポートは、世界の遺伝子治療市場について調査しており、市場の課題、成長要因、主な動向と開発 、予測、COVID-19の影響、細胞タイプ・ベクタータイプ・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 市場概要

  • イントロダクション
  • 遺伝子治療で治療される病気
  • 遺伝子治療のプロセス
  • 遺伝子治療のタイプ
  • 遺伝子治療の応用分野
  • 遺伝子治療技術
  • 遺伝子治療の長所と短所

第2章 COVID-19の影響

  • 経済的影響
  • 世界の GDPの低下
  • 産業・生産の減少
  • 遺伝子治療への影響
  • 遺伝子治療の臨床試験への影響

第3章 世界の市場分析(売上別)

  • 世界市場
  • 世界市場予測
  • 細胞タイプ別
    • 体細胞
    • 体細胞予測
    • 生殖細胞
    • 生殖細胞予測
  • ベクタータイプ別の市場
    • レトロウイルスおよびガンマレトロウイルス
    • レトロウイルスおよびガンマレトロウイルス:予測
    • アデノ随伴ウイルス
    • アデノ随伴ウイルス:予測
    • レンチウイルス
    • レンチウイルス:予測
    • アデノウイルス
    • アデノウイルス:予測
    • 修飾単純ヘルペスウイルス
    • 修飾単純ヘルペスウイルス:予測
    • 非ウイルスプラスミドベクター
    • 非ウイルスプラスミドベクター:予測
  • 用途別の市場
    • 腫瘍疾患
    • 腫瘍性疾患:予測
    • 神経障害
    • 神経障害:予測
    • 感染症
    • 感染症:予測
    • 循環器疾患
    • 循環器疾患:予測
    • 稀少疾患
    • 稀少疾患:予測
  • エンドユーザー別の市場
    • 病院および医院
    • 病院および医院:予測
    • 専門治療センター
    • 専門治療センター:予測
  • 地域別世界の市場

第4章 地域市場分析

  • 北米
    • 北米市場
    • 北米市場予測
  • 欧州
  • アジア太平洋
  • その他の地域

第5章 市場力学

  • 成長要因
    • 慢性疾患の有病率の増加
    • 増加するヘルスケア費
    • 拡大する都市化
    • 遺伝子治療の臨床試験の成長
    • 経済成長の高まり
  • 主な動向と開発
    • 個別化医薬品の迅速な採用
    • 遺伝性疾患の発生の増加
    • 遺伝子治療の進歩
    • 研究開発資金の増加
  • 課題
    • 遺伝子治療の副作用
    • 倫理的および安全上の懸念
    • 治療費の高さ

第6章 競合情勢

  • 世界の市場
    • 主要企業の収益比較
    • 主要企業の時価総額比較
    • 主要企業の研究開発比較

第7章 企業プロファイル

  • Roche Holding AG
  • Pfizer Inc.
  • Novartis International AG
  • GlaxoSmithKline PLC
  • Bristol Myers Squibb Co. (Celgene Corporation)
  • Gilead Sciences, Inc.
図表

List of Figures

  • Diseases Treated by Gene Therapy
  • Process of Gene Therapy
  • Types of Gene Therapy
  • Applications Areas for Gene Therapy
  • Gene Therapy Techniques
  • Advantages & Disadvantages of Gene Therapy
  • Breakdown of Direct and Indirect Costs of COVID-19 (2020)
  • Global GDP (2005-2020)
  • Decline in Chinese Industrial Production (2020)
  • Global Most Affected Clinical Trials by Therapy Area (2020)
  • Global Gene Therapy Market by Value (2015-2019)
  • Global Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by Cell Type (2019)
  • Global Somatic Cell Gene Therapy Market by Value (2015-2019)
  • Global Somatic Cell Gene Therapy Market Forecast by Value (2020-2024)
  • Global Germ Cell Gene Therapy Market by Value (2015-2019)
  • Global Germ Cell Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by Vector Type (2019)
  • Global Retrovirus & Gammaretrovirus Gene Therapy Market by Value (2015-2019)
  • Global Retrovirus & Gammaretrovirus Gene Therapy Market Forecast by Value (2020-2024)
  • Global Adeno-Associated Viruses Gene Therapy Market by Value (2015-2019)
  • Global Adeno-Associated Viruses Gene Therapy Market Forecast by Value (2020-2024)
  • Global Lentivirus Gene Therapy Market by Value (2015-2019)
  • Global Lentivirus Gene Therapy Market Forecast by Value (2020-2024)
  • Global Adenovirus Gene Therapy Market by Value (2015-2019)
  • Global Adenovirus Gene Therapy Market Forecast by Value (2020-2024)
  • Global Modified Herpes Simplex Virus Gene Therapy Market by Value (2015-2019)
  • Global Modified Herpes Simplex Virus Gene Therapy Market Forecast by Value (2020-2024)
  • Global Non-Viral Plasmid Vector Gene Therapy Market by Value (2015-2019)
  • Global Non-Viral Plasmid Vector Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by Application (2019)
  • Global Oncological Disorders Gene Therapy Market by Value (2015-2019)
  • Global Oncological Disorders Gene Therapy Market Forecast by Value (2020-2024)
  • Global Neurological Disorders Gene Therapy Market by Value (2015-2019)
  • Global Neurological Disorders Gene Therapy Market Forecast by Value (2020-2024)
  • Global Infectious Disease Gene Therapy Market by Value (2015-2019)
  • Global Infectious Disease Gene Therapy Market Forecast by Value (2020-2024)
  • Global Cardiovascular Diseases Gene Therapy Market by Value (2015-2019)
  • Global Cardiovascular Diseases Gene Therapy Market Forecast by Value (2020-2024)
  • Global Rare Diseases Gene Therapy Market by Value (2015-2019)
  • Global Rare Diseases Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by End-User (2019)
  • Global Hospitals & Clinics Gene Therapy Market by Value (2015-2019)
  • Global Hospitals & Clinics Gene Therapy Market Forecast by Value (2020-2024)
  • Global Specialty Treatment Centers Gene Therapy Market by Value (2015-2019)
  • Global Specialty Treatment Centers Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by Region (2019)
  • North America Gene Therapy Market by Value (2015-2019)
  • North America Gene Therapy Market Forecast by Value (2020-2024)
  • Europe Gene Therapy Market by Value (2015-2019)
  • Europe Gene Therapy Market Forecast by Value (2020-2024)
  • Europe Gene Therapy Market by Indication (2019)
  • Europe Large B-cell Lymphoma Gene Therapy Market by Value (2015-2019)
  • Europe Large B-cell Lymphoma Gene Therapy Market Forecast by Value (2020-2024)
  • Europe Inherited Retinal Disease Gene Therapy Market by Value (2015-2019)
  • Europe Inherited Retinal Disease Gene Therapy Market Forecast by Value (2020-2024)
  • Europe ADA-SCID Gene Therapy Market by Value (2015-2019)
  • Europe ADA-SCID Gene Therapy Market Forecast by Value (2020-2024)
  • Europe Acute Lymphoblastic Leukemia Gene Therapy Market by Value (2015-2019)
  • Europe Acute Lymphoblastic Leukemia Gene Therapy Market Forecast by Value (2020-2024)
  • Asia Pacific Gene Therapy Market by Value (2015-2019)
  • Asia Pacific Gene Therapy Market Forecast by Value (2020-2024)
  • RoW Gene Therapy Market by Value (2015-2019)
  • RoW Gene Therapy Market Forecast by Value (2020-2024)
  • Global Cancer Prevalence (2018-2023)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Urban Population (2014-2019)
  • Number of Gene Therapy Clinical Trials Approved Worldwide (2012-2019)
  • Global GDP Per Capita (2014-2019)
  • Global Personalized Medicine Market (2015-2022)
  • Global Sickle Cell Disease Treatment Market (2017-2023)
  • Roche Holding AG Sales and Net Income (2015-2019)
  • Roche Holding AG Sales by Segment (2019)
  • Pfizer Inc. Total Revenue and Profit (2015-2019)
  • Pfizer Inc. Revenue by Segment (2019)
  • Pfizer Inc. Revenue by Region (2019)
  • Novartis International AG Net Sales and Net Income (2015-2019)
  • Novartis International AG Net Sales by Segment (2019)
  • Novartis International AG Net Sales by Region (2019)
  • GlaxoSmithKline PLC Turnover and Profit (2015-2019)
  • GlaxoSmithKline PLC Turnover by Segment (2019)
  • GlaxoSmithKline PLC Turnover by Region (2019)
  • Bristol Myers Squibb Co. Total Revenue and Net Earnings (2015-2019)
  • Bristol Myers Squibb Co. Total Revenue by Region (2019)
  • Gilead Sciences, Inc. Revenue and Net Income (2015-2019)

List of Tables

  • Revenue Comparison of Key Players (2019)
  • Market Capitalization Comparison of Key Players (2020)
  • R&D Comparison of Key Players (2019)
目次

The global gene therapy market is expected to reach US$6.42 billion in 2024, witnessing growth at a CAGR of 19.29%, over the period 2020-2024. Growth in the gene therapy market has accrued due to the increasing prevalence of chronic diseases, rising healthcare expenditure, expanding urbanization, growth of gene therapy clinical trials and upsurge in economic growth. The market is anticipated to experience certain trends like rapid adoption of personalized medicine, growing occurrence of genetic disorders, advancements in gene therapy and increasing R&D funding. The growth of the market would be challenged by side effects of gene therapy and ethical and safety concerns and high cost of the treatment.

The global gene therapy market has been segmented on the basis of cell type, vector type, application, end-user and region. Depending on the cell type, the market can be bifurcated into somatic cell gene therapy and germ cell gene therapy. According to the vector type, the global gene therapy market can be categorized into retrovirus & gammaretrovirus, adeno-associated viruses (AAV), lentivirus, adenovirus, modified herpes simplex virus and non-viral plasmid vector. Whereas, on the basis of application, the market can be split into oncological disorders, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases and others. Further, in terms of end-user, the global gene therapy market can broadly be segmented into hospitals, specialty treatment centers and other end-users.

The fastest growing regional market is North America due to the rising incidence of cancer and other target diseases, increasing favorable reimbursement scenario in the region and improvements in healthcare infrastructure. Further, the sudden outbreak of COVID-19 is causing an adverse disruption on the overall economy and society, affecting the rate of gene therapy procedures and clinical trials, which is expected to negatively impact the growth of the global gene therapy market during the forecasted period.

Scope of the report:

  • The report provides a comprehensive analysis of the global gene therapy market segmented on the basis of cell type, vector type, application, end-user and region.
  • The major regional and country markets (North America, Europe, Asia Pacific and Rest of the World) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Pfizer Inc., Novartis International AG, GlaxoSmithKline PLC, Bristol Myers Squibb Co. (Celgene Corporation) and Gilead Sciences, Inc.) are also presented in detail.

Key Target Audience:

  • Gene Therapy Manufacturers
  • End Users (Hospitals, Specialty Treatment Centers & Others)
  • Research Institutes and Organizations
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Diseases Treated by Gene Therapy
  • 1.3 Process of Gene Therapy
  • 1.4 Types of Gene Therapy
  • 1.5 Application Areas for Gene Therapy
  • 1.6 Gene Therapy Techniques
  • 1.7 Advantages & Disadvantages of Gene Therapy

2. Impact of COVID-19

  • 2.1 Economic Impact
  • 2.2 Decline in Global GDP
  • 2.3 Decline in Industrial Production
  • 2.4 Impact on Gene Therapy
  • 2.5 Impact on Clinical Trials of Gene Therapy

3. Global Market Analysis

  • 3.1 Global Gene Therapy Market by Value
  • 3.2 Global Gene Therapy Market Forecast by Value
  • 3.3 Global Gene Therapy Market by Cell Type
    • 3.3.1 Global Somatic Cell Gene Therapy Market by Value
    • 3.3.2 Global Somatic Cell Gene Therapy Market Forecast by Value
    • 3.3.3 Global Germ Cell Gene Therapy Market by Value
    • 3.3.4 Global Germ Cell Gene Therapy Market Forecast by Value
  • 3.4 Global Gene Therapy Market by Vector Type
    • 3.4.1 Global Retrovirus & Gammaretrovirus Gene Therapy Market by Value
    • 3.4.2 Global Retrovirus & Gammaretrovirus Gene Therapy Market Forecast by Value
    • 3.4.3 Global Adeno-Associated Viruses Gene Therapy Market by Value
    • 3.4.4 Global Adeno-Associated Viruses Gene Therapy Market Forecast by Value
    • 3.4.5 Global Lentivirus Gene Therapy Market by Value
    • 3.4.6 Global Lentivirus Gene Therapy Market Forecast by Value
    • 3.4.7 Global Adenovirus Gene Therapy Market by Value
    • 3.4.8 Global Adenovirus Gene Therapy Market Forecast by Value
    • 3.4.9 Global Modified Herpes Simplex Virus Gene Therapy Market by Value
    • 3.4.10 Global Modified Herpes Simplex Virus Gene Therapy Market Forecast by Value
    • 3.4.11 Global Non-Viral Plasmid Vector Gene Therapy Market by Value
    • 3.4.12 Global Non-Viral Plasmid Vector Gene Therapy Market Forecast by Value
  • 3.5 Global Gene Therapy Market by Application
    • 3.5.1 Global Oncological Disorders Gene Therapy Market by Value
    • 3.5.2 Global Oncological Disorders Gene Therapy Market Forecast by Value
    • 3.5.3 Global Neurological Disorders Gene Therapy Market by Value
    • 3.5.4 Global Neurological Disorders Gene Therapy Market Forecast by Value
    • 3.5.5 Global Infectious Disease Gene Therapy Market by Value
    • 3.5.6 Global Infectious Disease Gene Therapy Market Forecast by Value
    • 3.5.7 Global Cardiovascular Diseases Gene Therapy Market by Value
    • 3.5.8 Global Cardiovascular Diseases Gene Therapy Market Forecast by Value
    • 3.5.9 Global Rare Diseases Gene Therapy Market by Value
    • 3.5.10 Global Rare Diseases Gene Therapy Market Forecast by Value
  • 3.6 Global Gene Therapy Market by End-User
    • 3.6.1 Global Hospitals & Clinics Gene Therapy Market by Value
    • 3.6.2 Global Hospitals & Clinics Gene Therapy Market Forecast by Value
    • 3.6.3 Global Specialty Treatment Centers Gene Therapy Market by Value
    • 3.6.4 Global Specialty Treatment Centers Gene Therapy Market Forecast by Value
  • 3.7 Global Gene Therapy Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Gene Therapy Market by Value
    • 4.1.2 North America Gene Therapy Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Gene Therapy Market by Value
    • 4.2.2 Europe Gene Therapy Market Forecast by Value
    • 4.2.3 Europe Gene Therapy Market by Indication
    • 4.2.4 Europe Large B-Cell Lymphoma Gene Therapy Market by Value
    • 4.2.5 Europe Large B-Cell Lymphoma Gene Therapy Market Forecast by Value
    • 4.2.6 Europe Inherited Retinal Disease Gene Therapy Market by Value
    • 4.2.7 Europe Inherited Retinal Disease Gene Therapy Market Forecast by Value
    • 4.2.8 Europe ADA-SCID Gene Therapy Market by Value
    • 4.2.9 Europe ADA-SCID Gene Therapy Market Forecast by Value
    • 4.2.10 Europe Acute Lymphoblastic Leukemia Gene Therapy Market by Value
    • 4.2.11 Europe Acute Lymphoblastic Leukemia Gene Therapy Market Forecast by Value
  • 4.3 Asia Pacific
    • 4.3.1 Asia Pacific Gene Therapy Market by Value
    • 4.3.2 Asia Pacific Gene Therapy Market Forecast by Value
  • 4.4 RoW
    • 4.4.1 RoW Gene Therapy Market by Value
    • 4.4.2 RoW Gene Therapy Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Rising Healthcare Expenditure
    • 5.1.3 Expanding Urbanization
    • 5.1.4 Growth of Gene Therapy Clinical Trials
    • 5.1.5 Upsurge in Economic Growth
  • 5.2 Key Trends and Developments
    • 5.2.1 Rapid Adoption of Personalized Medicines
    • 5.2.2 Growing Occurrence of Genetic Disorders
    • 5.2.3 Advancements in Gene Therapy
    • 5.2.4 Increasing R&D Funding
  • 5.3 Challenges
    • 5.3.1 Side Effects of Gene Therapy
    • 5.3.2 Ethical and Safety Concerns
    • 5.3.3 High Cost of Treatment

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Revenue Comparison of Key Players
    • 6.1.2 Market Capitalization Comparison of Key Players
    • 6.1.3 R&D Comparison of Key Players

7. Company Profiles

  • 7.1 Roche Holding AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Pfizer Inc.
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Novartis International AG
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 GlaxoSmithKline PLC
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Bristol Myers Squibb Co. (Celgene Corporation)
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 Gilead Sciences, Inc.
    • 7.6.1 Business Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.